Key Market Indicators
The sales of diabetes medicine in Spain is projected to reach nearly $2.7 billion by 2026, having grown at a rate of 2.8% year on year since 2009. Canada topped the 2021 ranking with $2.3 billion, followed by Spain in third place and Italy in fourth. Meanwhile, Spanish insulin imports are forecast to reach $268.5 million by 2026, having increased at an average rate of 1% year on year since 1994. Furthermore, Spanish insulin exports are estimated to reach $46.8 million by 2026, having gone down 3.3% year on year since 1994. The United Arab Emirates was the top exporter in 2021, followed by France, Italy and China.
